Skip to main content

Advertisement

Log in

Ursodeoxycholic Acid in the Prevention of Gallstone Formation After Bariatric Surgery: an Updated Systematic Review and Meta-analysis

  • Review Article
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

We aim to review the available literature on obese patients treated with ursodeoxycholic acid (UDCA) in order to prevent gallstone formation after bariatric surgery. A systematic literature search was performed in PubMed, Cochrane library, and Scopus databases, in accordance with the PRISMA guidelines. Eight studies met the inclusion criteria incorporating 1355 patients. Random-effects meta-analysis showed a lower incidence of gallstone formation in patients taking UDCA. Subgroup analysis reported fewer cases of gallstone disease in the UDCA group in relation to different bariatric procedures, doses of administered UDCA, and time from bariatric surgery. Adverse events were similar in both groups. Fewer patients required cholecystectomy in UDCA group. No deaths were reported. The administration of UDCA after bariatric surgery seems to prevent gallstone formation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Go AS, Mozaffarian D, Roger VL, et al. Executive summary: heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation. 2013;127:143–52.

    Article  PubMed  Google Scholar 

  2. Colquit JL, Picot J, Loveman E, et al. Surgery for obesity. Cochrane Database Syst Rev. 2009;2:CD003641.

    Google Scholar 

  3. Magouliotis DE, Tasiopoulou VS, Sioka E, et al. Robotic versus laparoscopic sleeve gastrectomy for morbid obesity: a systematic review and meta-analysis. Obes Surg. 2017;27:245. https://doi.org/10.1007/s11695-016-2444-1.

    Article  PubMed  Google Scholar 

  4. Magouliotis DE, Tasiopoulou VS, Svokos AA, et al. One-anastomosis gastric bypass versus sleeve gastrectomy for morbid obesity: a systematic review and meta-analysis. Obes Surg. 2017;27(9):2479–87. https://doi.org/10.1007/s11695-017-2807-2.

    Article  PubMed  Google Scholar 

  5. Stampfer MJ, Maclure KM, Colditz GA, et al. Risk of symptomatic gallstones in women with severe obesity. Am J Clin Nutr. 1992;55:652–8.

    CAS  PubMed  Google Scholar 

  6. Worobetz LJ, Inglis FG, Shaffer EA. The effect of ursodeoxycholic acid therapy on gallstone formation in the morbidly obese during rapid weight loss. Am J Gastroenterol. 1993;88(10):1705–10.

    CAS  PubMed  Google Scholar 

  7. Friedman GD. Natural history of asymptomatic and symptomatic gallstones. Am J Surg. 1993;165:399–404.

    Article  CAS  PubMed  Google Scholar 

  8. Everhart JE, Ruhl CE. Burden of digestive diseases in the United States part III: liver, biliary tract, and pancreas. Gastroenterology. 2009;136:1134–44.

    Article  PubMed  Google Scholar 

  9. Broomfield PH, Chopra R, Sheinbaum RC, et al. Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weight. N Engl J Med. 1998;319(24):1567–72.

    Article  Google Scholar 

  10. Salvioli G, Igimi H, Carey MC. Cholesterol gallstone dissolution in bile: dissolution kinetics of crystalline cholesterol monohydrate by conjugated chenodeoxycholate-lecithin and conjugated ursodeoxycholate-lecithin mixtures—dissimilar phase equilibria and dissolution mechanisms. J Lipid Res. 1983;24:701–20.

    CAS  PubMed  Google Scholar 

  11. Sarr MG. Patients developed symptomatic gallstones between 3 and 21 months after Roux-en-Y gastric bypass (RYGB), neither prophylactic cholecystectomy nor treatment with ursodeoxycholic acid is necessary after open RYGB. Surg Obes Relat Dis. 2006;2(2):233.

    Article  PubMed  Google Scholar 

  12. Kim JJ, Schirmer B. Safety and efficacy of simultaneous cholecystectomy at Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2009;5(1):48–53. https://doi.org/10.1016/j.soard.2008.06.001.

    Article  PubMed  Google Scholar 

  13. Dorman RB, Zhong W, Abraham AA, et al. Does concomitant cholecystectomy at time of Roux-en-Y gastric bypass impact adverse operative outcomes? Obes Surg. 2013 Nov;23(11):1718–26. https://doi.org/10.1007/s11695-013-1001-4.

    Article  PubMed  Google Scholar 

  14. Tucker ON, Fajnwaks P, Szomstein S, et al. Is concomitant cholecystectomy necessary in obese patients undergoing laparoscopic gastric bypass surgery? Surg Endosc. 2008 Nov;22(11):2450–4. https://doi.org/10.1007/s00464-008-9769-3.

    Article  CAS  PubMed  Google Scholar 

  15. Weiss AC, Inui T, Parina R, et al. Concomitant cholecystectomy should be routinely performed with laparoscopic Roux-en-Y gastric bypass. Surg Endosc. 2015 Nov;29(11):3106–11. https://doi.org/10.1007/s00464-014-4033-5.

    Article  PubMed  Google Scholar 

  16. Wanjura V, Sandblom G, Österberg J, et al. Cholecystectomy after gastric bypass-incidence and complications. Surg Obes Relat Dis. 2017 Jun;13(6):979–87. https://doi.org/10.1016/j.soard.2016.12.004.

    Article  PubMed  Google Scholar 

  17. Uy MC, Talingdan-Te MC, Espinosa WZ, et al. Ursodeoxycholic acid in the prevention of gallstone formation after bariatric surgery: a meta-analysis. Obes Surg. 2008;18:1532–8.

    Article  PubMed  Google Scholar 

  18. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6:e1000100.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration 2011 Available from http://www.cochrane-handbook.org.

  20. Borenstein M, Hedges LV, Higgins JPT, et al. Introduction to meta-analysis. West Sussex: Wiley; 2009. p. 119. 283–287

    Book  Google Scholar 

  21. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603–5.

    Article  PubMed  Google Scholar 

  22. H.J. GSE. (2011) Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]

  23. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Abdallah E, Emile SH, Elfeki H, et al. Role of ursodeoxycholic acid in the prevention of gallstone formation after laparoscopic sleeve gastrectomy. Surg Today. 2016; https://doi.org/10.1007/s00595-016-1446-x.

  25. Adams LB, Chang C, Pope J, et al. Randomized, prospective comparison of ursodeoxycholic acid for the prevention of gallstones after sleeve gastrectomy. Obes Surg. 2016;26:990. https://doi.org/10.1007/s11695-015-1858-5.

    Article  PubMed  Google Scholar 

  26. Coupaye M, Calabrese D, Sami O, et al. Evaluation of incidence of cholelithiasis after bariatric surgery in subjects treated or not treated with ursodeoxycholic acid. Surg Obes Relat Dis. 2016:00–0. https://doi.org/10.1016/j.soard.2016.11.022.

  27. Miller K, Hell E, Lang B, et al. Gallstone formation prophylaxis after gastric restrictive procedures for weight loss: a randomized double-blind placebo-controlled trial. Ann Surg. 2003;238(5):697–702.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Sugerman HJ, Brewer WH, Shiffman ML, et al. A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss. Am J Surg. 1995;169:91–7.

    Article  CAS  PubMed  Google Scholar 

  29. Williams CN, Gowan R, Perey BJ. A double-blind placebo-controlled trial of ursodeoxycholic acid in the prevention of gallstones during weight loss after vertical banded gastroplasty. Obes Surg. 1993;3:257–9.

    Article  CAS  PubMed  Google Scholar 

  30. Wudel LJ, Wright JK, Debelak JP, et al. Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study. J Surg Res. 2002;102(1):50–6.

    Article  CAS  PubMed  Google Scholar 

  31. Magouliotis DE, Tasiopoulou VS, Sioka E, et al. Impact of bariatric surgery on metabolic and gut microbiota profile: a systematic review and meta-analysis. Obes Surg. 2017; https://doi.org/10.1007/s11695-017-2595-8.

  32. Caruana JA, McCabe MN, Smith AD, et al. Incidence of symptomatic gallstones after gastric bypass: is prophylactic treatment really necessary? Surg Obes Relat Dis. 2005;1:564–7.

    Article  PubMed  Google Scholar 

  33. Papasavas PK, Gagné DJ, Ceppa FA, et al. Routine gallbladder screening not necessary in patients undergoing laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2006;2:41–6.

    Article  PubMed  Google Scholar 

  34. Swartz DE, Felix EL. Elective cholecystectomy after Roux-en-Y gastric bypass: why should asymptomatic gallstones be treated differently in morbidly obese patients? Surg Obes Relat Dis. 2005;1:555–60.

    Article  PubMed  Google Scholar 

  35. Moon RC, Teixeira AF, Du Coin C, et al. Comparison of cholecystectomy cases after Roux-en-Y gastric bypass, sleeve gastrectomy, and gastric banding. Surg Obes Relat Dis. 2014;10(1):64–8.

    Article  PubMed  Google Scholar 

Download references

Funding

The authors received no financial support for the research, authorship, and/or publication of this article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dimitrios E. Magouliotis.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflicts of interest.

Ethical Approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Electronic supplementary material

Table S1

(DOCX 88 kb)

Table S2

(DOCX 78 kb)

Figure S1

(DOCX 277 kb)

Figure S2

(DOCX 235 kb)

ESM 1

(DOC 63 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Magouliotis, D.E., Tasiopoulou, V.S., Svokos, A.A. et al. Ursodeoxycholic Acid in the Prevention of Gallstone Formation After Bariatric Surgery: an Updated Systematic Review and Meta-analysis. OBES SURG 27, 3021–3030 (2017). https://doi.org/10.1007/s11695-017-2924-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-017-2924-y

Keywords

Navigation